Coronary physiology case review

Dr Sharp qualified from Edinburgh Medical School in 1998. He was appointed as a Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011, before moving to the University Hospital of Wales, in Cardiff, UK in the summer of 2019, where he is now Honorary Professor of Cardiology. He conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training. He completed the Milan-Imperial Interventional Cardiology Fellowship programme, having spent a year in San Raffaele and Columbus Hospitals, Milan, Italy, under the tutelage of Professor Antonio Colombo. He also spent three years training in interventional cardiology at St Mary’s Hospital and The Hammersmith Hospital (Imperial College Hospitals) in London. Prof Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and leads a large research programme in Wales. He has an international reputation for leading the development of device-based treatments for hypertension (in particular that of renal denervation) and pulmonary embolism, as well as the advancement of intracoronary imaging and physiology.

Dr Justin Davies is founder and CEO of Wondr Medical, inventor of iFR, and clinical academic and consultant interventional cardiologist at the National Heart and Lung Institute, Imperial College London.

Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK. Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is the lead author of the primary publication in The Lancet. At Imperial College, she is actively involved in the development and recruitment for a number of multi-centre clinical trials. Dr Al- Lamee has over 40 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career. She studied at the University of Oxford and University College London. She went onto complete her training as a junior doctor on the Barts and the London Medical rotation before being appointed as a Specialist Registrar on the North West London Cardiology rotation in 2006. Dr Al-Lamee has twelve years of Cardiology experience and completed three years of Interventional Fellowship training at Hammersmith Hospital in London. She also spent a year training as an Interventional Fellow under the supervision of Professor Antonio Colombo in Milan. She completed specialist training in Cardiology in 2013.

Professor Ravi Bhindi is a consultant and Interventional Cardiologist on the North Shore Hospital Campus. He has expertise in complex coronary intervention and structural heart disease including percutaneous valve therapies. He is Head of Clinical Trials and the Structural Heart disease at North Shore Private and Royal North Shore Hospitals. In addition to an active clinical role, he maintains active research programs and has over 100 publications in peer reviewed journals. Professor Bhindi completed his MBBS and PhD at the University of Sydney before undertaking further interventional cardiology training and postdoctoral fellowship at the John Radcliffe hospital/ University of Oxford.

Dr Waldemar Bojara is Head of the Department of Clinical and Interventional Cardiology at the Gemeinschaftsklinikum Mittelrhein, Kemperhof. He has led the developement of the department of interventional cardiology at the Gemeinschaftsklinikum Mittelrhein, Kemperhof. Dr. Bojara completed his medical education at Bergmannsheil Bochum, University Hospital in Germany. He continued his training in internal medicine and than interventional cardiology at the same institution, was responsible for the cathlabs and established the coronary physiology program as well as the TAVI program. He has a strong interest in coronary physiology since more than 25 years, in particular coronary pressure measurements, flow measurements, intracoronary ultrasound and interventional cardiology including the use of left ventricular assist devices (Impella pump and synchronized extracorporal mechanical circulatory support) for protected PCI- and cardiogenic shock patients.